moxifloxacin has been researched along with Ache in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Bucsa, C; Farcas, A; Huruba, M; Leucuta, DC; Mogosan, C; Sipos, M | 1 |
| Colucci, S; Harris, SC; Morganroth, J; Ripa, SR; Thorn, MD | 1 |
| Kenward, MG; Roger, JH | 1 |
| Bansal, S; Sachdev, R; Sharma, N; Sinha, R; Titiyal, JS | 1 |
| Bitterman, A; Chruscicki, DA; Cohn, S; Donnenfeld, E; Perry, HD; Solomon, R | 1 |
| Alefelder, M; Arvis, P; Cronjé, HS; Kureishi, A; Paszkowski, T; Rakoczi, I; Reimnitz, P; Ross, JD; Vildaite, D | 1 |
| Ogrendik, M | 1 |
4 trial(s) available for moxifloxacin and Ache
| Article | Year |
|---|---|
Effects of buprenorphine on QT intervals in healthy subjects: results of 2 randomized positive- and placebo-controlled trials.
Topics: Administration, Cutaneous; Adult; Arrhythmias, Cardiac; Aza Compounds; Buprenorphine; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluoroquinolones; Healthy Volunteers; Heart Rate; Humans; Male; Middle Aged; Moxifloxacin; Naltrexone; Pain; United States; Young Adult | 2017 |
A comparison of the fourth-generation fluoroquinolones gatifloxacin 0.3% and moxifloxacin 0.5% in terms of ocular tolerability.
Topics: Adult; Anterior Chamber; Aza Compounds; Conjunctiva; Eye; Female; Fluoroquinolones; Gatifloxacin; Humans; Hyperemia; Irritants; Male; Middle Aged; Moxifloxacin; Ophthalmic Solutions; Pain; Pupil; Quinolines | 2004 |
Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: results of a multicentre, double blind, randomised trial.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Aza Compounds; Double-Blind Method; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Metronidazole; Moxifloxacin; Ofloxacin; Pain; Pain Measurement; Pelvic Inflammatory Disease; Prospective Studies; Quinolines | 2006 |
Treatment of ankylosing spondylitis with moxifloxacin.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Antitubercular Agents; Aza Compounds; Biomarkers; Blood Sedimentation; C-Reactive Protein; Female; Fluoroquinolones; Follow-Up Studies; Humans; Male; Middle Aged; Moxifloxacin; Pain; Pain Measurement; Pilot Projects; Quinolines; Retrospective Studies; Severity of Illness Index; Spondylitis, Ankylosing; Treatment Outcome | 2007 |
3 other study(ies) available for moxifloxacin and Ache
| Article | Year |
|---|---|
A VigiBase descriptive study of fluoroquinolone induced disabling and potentially permanent musculoskeletal and connective tissue disorders.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Adverse Drug Reaction Reporting Systems; Arthralgia; Ciprofloxacin; Connective Tissue Diseases; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Middle Aged; Moxifloxacin; Musculoskeletal Diseases; Myalgia; Norfloxacin; Ofloxacin; Pain; Risk Factors; Tendinopathy; Tendons; Young Adult | 2021 |
The use of baseline covariates in crossover studies.
Topics: Algorithms; Analysis of Variance; Antihypertensive Agents; Aza Compounds; Bias; Blood Pressure; Bronchial Hyperreactivity; Controlled Clinical Trials as Topic; Cross-Over Studies; Electrocardiography; Epidemiologic Research Design; Fluoroquinolones; Forced Expiratory Volume; Heart Diseases; Humans; Hypertension; Likelihood Functions; Models, Statistical; Moxifloxacin; Nitric Oxide; Pain; Quinolines; Statistical Distributions | 2010 |
Bilateral microbial keratitis in highly active antiretroviral therapy-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a case series.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amnion; Anti-Bacterial Agents; Antiretroviral Therapy, Highly Active; Aza Compounds; Benzamidines; Carboxymethylcellulose Sodium; Cefazolin; Chlorhexidine; Corneal Ulcer; Drug Therapy, Combination; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Pain; Quinolines; Stevens-Johnson Syndrome; Tobramycin; Treatment Outcome; Tropanes; Visual Acuity | 2011 |